Innovasan Announces Successful Prototype Testing at TENN Graduation

“The treatment test resulted in a 6log or 99.9999% reduction in bacteria count.”

Release Date:
Monday, April 25, 2016
 
Knoxville, TN – Last Thursday April 21st Innovasan graduated from Launch Tennessee’s Master Accelerator program, the TENN. During the final presentation the six graduating companies discussed traction they have made over the previous six months on critical milestones.
 
Innovasan announced major progress across multiple milestones including successful completion of its Gauntlet Disinfection System Alpha Prototype and successful microbiology validation of the prototype at the University of Tennessee’s Center for Environmental Biotechnology. Working with researchers at UT’s CEB Innovasan treated a surrogate infectious liquid medical waste stream that had been inoculated with pseudomonas aeruginosa and e coli. The treatment test resulted in a 6log or 99.9999% reduction in bacteria count. According to Innovasan this level of treatment is considered “high level disinfection” by the FDA.  
 
Innovasan also announced their beta-site partnership with the University of Tennessee Medical Center and that it is currently in negotiations to finalize details of its first purchase order to be filled upon successful completion of the beta-site program.